Theriva Biologics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -27 | -27 | -26 | |
EBITDA | 6,896 | -4,333 | -13,105 | -4,370 |
EBIT | 6,869 | -4,361 | -13,132 | -4,396 |
Net Income | -3,506 | -4,361 | -13,058 | -4,324 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,882 | -4,338 | -4,728 | -4,756 |
Cash | 13,056 | 7,528 | 12,120 | 10,014 |
Basic Shares | 12,140 | 9,676 | 6,752 | 2,782 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -108 | -137 | -135 | -268 |
EBITDA | -14,912 | -19,290 | -21,956 | -19,205 |
EBIT | -15,020 | -19,427 | -22,091 | -19,290 |
Net Income | -25,249 | -25,653 | -18,349 | -19,685 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,704 | -16,938 | -19,198 | -19,198 |
Cash | 13,056 | 11,609 | 23,177 | 41,786 |
Basic Shares | 12,140 | 1,348 | 644 | 613 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.09 |
2025-09-30 | -$0.45 |
2025-06-30 | -$1.93 |
2025-03-31 | -$1.55 |
